What is Innoviva, Inc.'s R&D?

Innoviva, Inc. (INVA) reported R&D of $5.24M in Q1 2026.

How has Innoviva, Inc.'s R&D changed year-over-year?

Innoviva, Inc.'s R&D increased by 19.2% year-over-year, from $4.4M to $5.24M.

What is the long-term trend for Innoviva, Inc.'s R&D?

Over 4 years (2021 to 2025), Innoviva, Inc.'s R&D has grown at a 170.0% compound annual growth rate (CAGR), from $576K to $30.6M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Innoviva, Inc. INVA R&D

R&D at other companies

Merck & Co.MRK

$12.59B+248%

InsmedINSM

$209.49M+37.3%

Ionis PharmaceuticalsIONS

$228.9M+1.6%

ArriVent BioPharma, Inc.AVBP

$37.62M-38.6%

Ligand PharmaceuticalsLGND

$2.15M-95.7%

AlkermesALKS

$103.35M+43.9%

Other financials

Income statement

See full

Revenue$98.0M+10.6%

Gross profit$75.8M+3.4%

Operating income$38.2M-7.9%

Net income$186.6M+501%

EPS (diluted)$2.22+400%

Balance sheet

See full

Cash & equivalents$603.1M+89.0%

Total debt$269.4M-40.3%

Total equity$1.3B—

Total assets$1.8B+46.4%

Cash flow

See full

Operating cash flow$35.3M-27.4%

CapEx$492.0K—

Free cash flow$34.8M-28.4%

Valuation

See full

Market cap$1.74B+51.8%

Enterprise value$1.41B+9.7%

P/E3.5×—

P/S4.2×+1.0×

Profitability

See full

Gross margin73.7%-9.9pp

Operating margin38.1%-11.2pp

Net margin119.9%+107pp

FCF margin54.1%+5.3pp

Returns & leverage

See full

Return on equity29.1%—

Debt / equity0.2×—

Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Innoviva, Inc.'s R&D?: Innoviva, Inc. (INVA) reported R&D of $5.24M in Q1 2026.
How has Innoviva, Inc.'s R&D changed year-over-year?: Innoviva, Inc.'s R&D increased by 19.2% year-over-year, from $4.4M to $5.24M.
What is the long-term trend for Innoviva, Inc.'s R&D?: Over 4 years (2021 to 2025), Innoviva, Inc.'s R&D has grown at a 170.0% compound annual growth rate (CAGR), from $576K to $30.6M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.